44 employees
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
1987
$6.9M
from 2 investors over 2 rounds
Immutep Limited raised $6.9M on July 9, 2019
Investors: Australian Ethical Investment and Altium Capital